GlassScriptPhysician profile
Luis Gude
NPI 1871029256
$4,328.22
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $239 · 2022: $408 · 2023: $2,127 · 2024: $1,554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,287 · Travel and Lodging: $1,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,287.22 |
| Travel and Lodging | $1,394.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,311.89 | 2023-2024 | Vanta Adaptivestim, Intellis Adaptivestim, Synchromedii |
| Abbott Laboratories | $551.21 | 2023-2024 | Proclaim, Eterna |
| Boston Scientific Corporation | $353.61 | 2024 | Wavewriter Alpha Prime 16 |
| Mml US, INC. | $327.57 | 2024 | Reactiv8 |
| Abbvie INC. | $263.90 | 2022-2023 | |
| Painteq LLC | $259.39 | 2022 | |
| Allergan, INC. | $238.77 | 2021 | |
| Merz Pharmaceuticals, LLC | $21.88 | 2023 | Xeomin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Gude listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.